<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments

Neuro Therapies

A New View: AI-Driven Imaging

In this article, SmartTRAK reviews the development of AI in healthcare and profiles four companies imple...

Neuro Therapies

NANS 2022: What's New for Abbott Neuromodulation

Abbott’s Allen Burton, MD discusses the Company’s new MRI labeling, expanded payer coverage for DRG, big...

Neuro Therapies

Medtronic: The Future of Neuromodulation in 2022 and Beyond

Medtronic Neuromodulation executives Dave Anderson and Charlie Covert discuss the Company and the future...

Neuro Therapies

An Interview with Nevro's D. Keith Grossman

D. Keith Grossman, chairman, CEO and president of Nevro Corporation, discusses the Company, expanding in...

Neuro Therapies

Meet Shelly Caruso - Market Analyst/Medical Writer

We are pleased to announce that Shelly Caruso has joined the team at SmartTRAK as a Market Analyst/Medic...

Neuro Therapies

SCS Boomerangs Back: Q221 Market Report

A big boost in Q2 with double-digit gains in all segments. The US and WW SCS Market boomeranged to pre-C...

Neuro Therapies

An Interview with Medtronic's Brett Wall

Brett Wall, EVP and President of Medtronic’s Neuroscience Portfolio, discusses changes and opportunities...

Neuro Therapies

Neuromodulation Ramping Up in 2021

As in-person meetings start to ramp up in 2021, SmartTRAK identifies the latest research, technologies a...

Neuro Therapies

RapidAI: Optimizing Outcomes with AI-Based Imaging

RapidAI President and CEO Don Listwin discusses how advances in AI-based imaging, workflow and products ...

Neuro Therapies

Aleva Neurotherapeutics: Improving Precision with a Next-Gen DBS

In an interview with SmartTRAK, André Mercanzini, founder and CEO of Aleva Neurotherapeutics, discusses ...

1
...
5 6 7
...
14